Literature DB >> 2347901

Basal plasma growth hormone levels in man: new evidence for rhythmicity of growth hormone secretion.

L M Winer1, M A Shaw, G Baumann.   

Abstract

Circulating GH levels in man fluctuate widely due to pulsatile GH secretion by the pituitary gland. During much of the time, plasma GH is undetectable by current assays. This is punctuated by occasional secretory episodes, resulting in plasma GH peaks of varying height. The principal diurnal secretory event for GH is that associated with early slow wave sleep, but little is known about the prevailing level and dynamics of GH during the day. We used a new ultrasensitive immunoradiometric assay for GH (Boots-Celltech IRMA; limit of detection, 20 ng/L) to measure plasma GH in the previously undetectable range and to assess its diurnal pattern. Plasma GH was measured every 20 min over a 24-h period in 12 normal subjects (6 men and 6 women, aged 20-47 yr) under physiological conditions. Time series analysis of plasma GH patterns was performed by the Cluster algorithm, autocorrelation, and spectral analysis. Plasma GH, as measured by IRMA, was detectable at all time points and ranged from 40-19,695 ng/L. Dynamic fluctuations occurred within and above the previously undetectable range, with amplitudes varying over 3 orders of magnitude. Women had significantly higher overall GH levels, higher peak amplitudes, and higher valley levels/nadirs than men. GH pulses occurred with an average frequency of about 13/day in both sexes, with a dominant, but not strictly periodic, 2-h rhythmicity. We conclude that in man pulsatile GH secretion occurs throughout the day, and that it is oscillatory rather than episodic. This neurosecretory pattern has eluded recognition heretofore because of the lack of assay sensitivity. Women of reproductive age have higher pulse amplitudes and a higher baseline but equal pulse frequency compared to men. Previous estimates of integrated GH concentrations and GH production rates were too high by a factor of 2 due to overestimation of GH levels in the undetectable range.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2347901     DOI: 10.1210/jcem-70-6-1678

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  28 in total

1.  Gender modulates sequential suppression and recovery of pulsatile growth hormone secretion by physiological feedback signals in young adults.

Authors:  Johannes D Veldhuis; Leon Farhy; Arthur L Weltman; Jonathan Kuipers; Judith Weltman; Laurie Wideman
Journal:  J Clin Endocrinol Metab       Date:  2005-02-22       Impact factor: 5.958

2.  Evaluation of growth hormone response to GHRH plus arginine test in children with idiopathic short stature: role of peak time.

Authors:  M Castagno; A Monzani; S Zanetta; G Genoni; E Giglione; R Ricotti; G Bona; F Prodam; S Bellone
Journal:  J Endocrinol Invest       Date:  2018-02-08       Impact factor: 4.256

3.  Immunolike growth hormone substance in tissues from human embryos/fetuses and adults.

Authors:  A Costa; G Zoppetti; C Benedetto; E Bertino; L Marozio; C Fabris; R Arisio; G F Giraudi; O Testori; M Ariano
Journal:  J Endocrinol Invest       Date:  1993-09       Impact factor: 4.256

4.  Gender-related differences in growth hormone-releasing pituitary adenomas. A clinicopathological study.

Authors:  Bernhard Schaller
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

5.  Gender- and age-related differences in the endocrine parameters of acromegaly.

Authors:  A Colao; G Amato; A M Pedroncelli; R Baldelli; S Grottoli; V Gasco; M Petretta; C Carella; G Pagani; G Tambura; G Lombardi
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

6.  Hypothesis: Neuroendocrine Mechanisms (Hypothalamus-Growth Hormone-STAT5 Axis) Contribute to Sex Bias in Pulmonary Hypertension.

Authors:  Pravin B Sehgal; Yang-Ming Yang; Edmund J Miller
Journal:  Mol Med       Date:  2015-07-30       Impact factor: 6.354

7.  Effect of obesity on endogenous secretion of growth hormone in Turner's syndrome.

Authors:  P W Lu; C T Cowell; M Jimenez; J M Simpson; M Silink
Journal:  Arch Dis Child       Date:  1991-10       Impact factor: 3.791

8.  Gender and age in the biochemical assessment of cure of acromegaly.

Authors:  P U Freda; R E Landman; R E Sundeen; K D Post
Journal:  Pituitary       Date:  2001-08       Impact factor: 4.107

9.  Growth hormone substitution titrated to obtain IGF-I levels in the physiological range in hypopituitary adults: effects upon dynamic strength, endurance and EMG.

Authors:  Bertil Ekman; Björn Gerdle; Hans J Arnqvist
Journal:  Eur J Appl Physiol       Date:  2003-07-26       Impact factor: 3.078

10.  Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. Modeling analysis and clinical applications.

Authors:  J D Veldhuis; M L Johnson; L M Faunt; M Mercado; G Baumann
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.